weight loss with compounded semaglutide My 6 Month Journey! FDA Warns Against Using Compounded

Interventions targeting microbiota are a prospective avenue for slowing disease progression

In the retatrutide phase 2 trial at 48 weeks, the 12 mg group reported 100% of participants losing at least 5%, 93% losing at least 10%, and 83% losing at least 15% though this was a smaller, earlier-stage study

How gut health triggers GLP-1: When your gut bacteria are happy and healthy, they send signals to increase GLP-1 production, which helps manage hunger and blood sugar

In patients with MASH and F1-F3 stage fibrosis treated with survodutide for 48 weeks across doses ranging from 2.4 to 6.0 mg, regression of MASH without fibrosis progression did not show a dose-dependent trend, with the best response observed at 4.8 mg (62% vs